Professor David Morris, a Non-Executive Director of PharmAust Limited has advised the board that he intends to retire a as a director of the company, effective from the close of the Annual General Meeting.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.18 AUD | 0.00% | -2.70% | +56.52% |
05-17 | PharmAust Appoints Nonexecutive Chair; Shares Up 3% | MT |
05-17 | PharmAust Obtains Orphan Drug Designation for Monepantel; Shares Up 5% | MT |
1st Jan change | Capi. | |
---|---|---|
+56.52% | 47.31M | |
+37.74% | 723B | |
+34.69% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.21% | 244B | |
+9.99% | 208B | |
-4.13% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- PAA Stock
- News PharmAust Limited
- David Morris to Retire as Director of PharmAust Limited